DERM
NASDAQ · Pharmaceuticals
Journey Medical Corp
$6.22
+0.30 (+5.07%)
Open$6.04
Previous Close$5.92
Day High$6.25
Day Low$5.83
52W High$9.56
52W Low$4.31
Volume—
Avg Volume245.3K
Market Cap171.26M
P/E Ratio—
EPS$-0.38
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+151.8% upside
Current
$6.22
$6.22
Target
$15.66
$15.66
$10.95
$15.66 avg
$21.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 68.10M | 72.19M | 106.46M |
| Net Income | -12,584,597 | -12,005,657 | 19.04M |
| Profit Margin | -18.5% | -17.6% | 17.9% |
| EBITDA | -4,309,941 | -4,340,093 | 19.03M |
| Free Cash Flow | — | — | 11.82M |
| Rev Growth | -5.7% | -5.7% | +23.5% |
| Debt/Equity | 0.79 | 0.79 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |